NCT05880355View on ClinicalTrials.gov

Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2026

Primary Completion Date

December 31, 2028

Study Completion Date

January 30, 2029

Conditions
Myocardial Infarction
Interventions
DRUG

Dapansutrile

Oral inhibitor of NLRP3

OTHER

Placebo

Non-active placebo

Trial Locations (1)

22908

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT05880355 - Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI | Biotech Hunter | Biotech Hunter